Christina England
vactruth.com
07/26/2010

In Perth this week, parents have been asked to volunteer their children between the ages of six months and two years, for participation in a vaccine trial.

In their report Vaccine trial targets kids ABC News explains that parents are being asked to register their children for a worldwide vaccine trial aimed at preventing a common cause of chest infections. These children will receive three doses of a vaccine for bronchiolitis, through nasal drops and will require a follow up blood test.

Dr Peter Richmond who heads up the ‘Vaccine Trials Group’ and is the main media spokesperson for VTG studies that are testing the vaccine in Perth, says that they are looking for healthy children for the trial.

“It’s really important that we’re able to develop vaccines that can prevent these serious infections in young children and keep them as healthy as possible and out of hospital.“

However, should parents ever be asked to use their ‘healthy children’ as drug company lab rats? Using children in experiments is highly dangerous, especially as the group of children required for this experiment are in a crucial stage of their development. If this vaccine has not been tested, how can VTG be sure that their vaccine will not interact with other vaccines that these children will have already had? According to vaccine schedule, children have already had around 18 vaccines by the age of two, some of these vaccines such as the DTaP and the MMR are triple vaccines.

Immunization Schedule In The USA

If we add another three doses of an untested vaccine, to the cocktail of adjuvants and chemicals that these children have already been subjected to, we could be adding the flame needed to ignite an already ticking time bomb.

We need to consider the fact that vaccines are drugs and to indicate just how dangerous drug trials can be, I would like to reference one drugs trial that went horribly wrong in the UK.

Fiona Macrea of the Daily Mail took up the story at the time in her article Elephant Man drug trial victims ‘injected too quickly’ | Mail Online

“The six young men – all fit and healthy before signing up for the March trial at Northwick Park Hospital in North-West London – suffered a host of side-effects, including pain, vomiting and organ failure.

Bar manager Mohamed ‘Nino’ Abdelhady, 28, was described as ‘the Elephant Man’ by his partner Myfanwy Marshall after his head swelled up.

Trainee plumber Ryan Wilson, 20, suffered heart, kidney and liver failure, pneumonia and blood poisoning and was in a coma for three weeks.
While in the coma, he suffered a frostbite-like reaction and has since lost parts of his fingers and had his toes amputated.”

In another report Drug-test victim’s ‘hell’ | The Sun |Newsone victim described his ordeal:-

“Then somehow the pain got even worse with the pressure in my head so intense it was like a truck had been parked on it.

“It felt like a terrible nightmare. I was aware of nothing around me just the pressure growing stronger and stronger in my skull.

“The nurses tried to calm me but suddenly the pain shot from my head to my spine as though the truck had been moved to my back.

“This felt even worse than before and I was conscious of bucking and writhing in the bed as they tried to get an oxygen mask on me.

“I started to think that these people were killing me and that I was going to die in this terrible place.

“As the mask was put on my face I felt that I couldn’t breathe and begged the doctors, Please, please let me out of here. I don’t want the money any more I just want to be free.’

“The agony didn’t end until I felt a needle go into my left arm with what must have been a sedative.

“Moments later I fell unconscious but it was only the start of the most terrifying hours of my life.”

The volunteers used in this trial, were consenting adults who made an informed decision to take part in this trial. They signed consent forms and knew of the risks. The babies to be used in the forthcoming vaccine trials will not be allowed this luxury but it is the babies themselves that may have to live with lifelong disabilities if this trial goes horribly wrong.

I would urge any parent to think very carefully before considering putting their baby forward for any drug or vaccine trial however tempting it may be, things can and do go wrong.

Catherine J. Frompovich
vactruth.com
07/15/2010

What do peanuts and vaccines have in common? Well, you’re probably thinking that some people have allergic reactions to both, and you are correct. Peanuts cause the most common severe food allergy reactions. Vaccines, on the other hand, that are grown on chicken eggs (MMR and influenza vaccines in particular) cause allergic reactions for which pharmaceutical and vaccine makers willingly provide cautionary notices on vaccine package inserts. It’s important to note that technically there can be two responses: a reaction, e.g., immediate allergic response (anaphylaxis), and a side effect, e.g., fever, rash, or localized swelling later on.

As an aside, vaccine makers would like to get away from growing vaccines on eggs for several reasons. In the April 11, 2007 issue of the Journal of the American Medical Association (JAMA) the article “Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine” by John J. Treanor, MD, et al, stated:

In this study, we evaluated an experimental influenza vaccine consisting of recombinant HA expressed in insect cells by a recombinant baculovirus (rHA0). This alternative avoids dependence on eggs and is very efficient because of the high levels of protein expression under the control of the baculovirus polyhedrin promoter. http://jama.ama-assn.org/cgi/content/full/297/14/1577

In essence, researchers produced vaccines grown on insect cells. If that vaccine production technology will be used or substituted for fertile egg mediums in the future, what cautionary information will appear on vaccine package inserts about bugs?

Allergic reactions to vaccines used to be of prime concern to pharmaceutical and vaccine makers. That changed after the passage of the Public Readiness and Emergency Preparedness Act of 2006 [PREP Act 42USC 247(d)-6d)] that, basically, exonerates vaccine makers of any damages from vaccines and/or vaccinations. A special vaccine court has been established from which harmed individuals must seek permission to bring legal charges. Common tort law no longer applies to vaccine/vaccination injury/damage.

What peanuts have in common with vaccines is something that very few healthcare consumers and medical doctors may be aware of: Peanut oil is a hidden and non-stated ingredient in the manufacture of children’s vaccines. This was brought to light in a 2010 court case wherein parents were accused of Shaken Baby Syndrome; had their child taken from them and placed in foster care for almost eight months; and Harold E. Buttram, MD, presented corroborating medical information to the court regarding the anaphylactic reaction the six-month old baby boy experienced resulting in tremendous swelling and pressure of the brain.

In Doctor Buttram’s paper presented for publication, “Subdural Hemorrhages Occurring in an Infant Immediately Following Vaccination,” he methodically charts the infant’s anamnestic allergic response to vaccines at four months of age. An anamnestic allergic response is a secondary immune response resulting from exposure to a previously encountered antigen. Such responses should preclude further administration of all vaccines.

Immediately following routine 6-month vaccines Pentacel [DTaP-IPV/Hib vaccine], Prevnar7 [Pneumococcal 7-valent Conjugate Vaccine], and Rotateq [Rotavirus Vaccine], the infant suffered an explosive rupturing of a facial hemangioma [abnormal buildup of blood vessels] and traumatic brain injury confirmed by a brain MRI [Magnetic Resonance Imaging].

Let’s consider the components that make up the Pentacel vaccine: Aluminum phosphate, bovine serum albumin, formaldehyde, glutaraldhyde, MRC-5, DNA and cellular protein, neomycin, polymyxin b sulfate, polysorbate 80, 2-phenoxyethanol. [1]

The two other vaccines administered simultaneously to the infant had equally remarkable ingredients. In the hopes of keeping this article as brief as possible, I’ve elected not to include their makeup.

Two days after the above-administered vaccines, a brain MRI showed extensive bilateral subdural hematomas [collection of blood outside blood vessels in both sides of the brain], something often thought to be due to trauma associated with Shaken Baby Syndrome.

Buttram noted that the scheduled and administered 4-month vaccines contained aluminum and unlabeled peanut oil. Furthermore, the infant’s mother observed noticeable enlargement and puffiness of the right strawberry-shaped facial hemangioma. Additionally, during 52 days of hospitalization, the infant was vaccinated further with the Hepatitis B vaccine. Medical records indicate tremendous head enlargement in a 30-day period, which could indicate hydrocephalus and/or brain hemorrhage.

Since Doctor Buttram was the expert witness for the defense (the child’s parents, who had the child taken away from them by civil authorities contending Shaken Baby Syndrome), he investigated and prepared a time line and inventory of the various vaccines administered along with the infant’s reactions and attending medical personnel witness statements as to the explosive rupturing of the facial hemangioma immediately after the injection while the infant was screaming dramatically.

Buttram found that yeast protein—a potent allergen—and peanut oil were used as adjuvants but not listed on the vaccine inserts. It was Doctor Buttram’s contention that both these adjuvants caused the hemangioma’s explosive reaction.

As part of his researched testimony, Doctor Buttram chronicled the use of peanut oil in vaccines, which proves rather interesting. After penicillin was invented (1945) researchers found that the kidneys excreted it within 3 hours thereby rendering it ineffective. In order to prolong penicillin’s action it was mixed with 4 to 4.8 percent beeswax and peanut oil. As a result, penicillin was slowly released as the body metabolized the oil. To further extend penicillin’s effects, penicillin with aluminum monostearate was added to make a solution suspended in peanut oil that kept blood levels of penicillin up to 24 to 26 hours. In 1964 Merck produced the adjuvant 65-4 that contained up to 65 percent peanut oil plus Arlasel A, aluminum stearate, and other ingredients with 13-fold higher levels of antibodies than previous vaccines. During the 1970s and 1980s peanut oil became a common practice and ingredient in vaccines. Coincidentally, peanut allergies began rising exponentially in children as more vaccines were administered. Heather Fraser in her 2010 book, The History of the Peanut Allergy Epidemic, documents this.

Concomitantly, hospital records indicate anaphylaxis reactions to vaccines. In the USA there were rising incidences of food anaphylaxis in children under five years of age. Hospital records in the USA further indicate that Emergency Room records indicated an increase of anaphylaxis from 671 per 100,000 during 1992-94 to 876 per 100,000 in 1995. More than 90 percent of all food allergy fatalities were documented as due to ingestion of peanuts and tree nuts, a 1991 study revealed. Nevertheless, in 2009 the prevalence of peanut allergy in children under 18 years of age amounted to more than 2 percent in both the United States and Britain. Additionally, in the U.S. during 2009, about 4.5 million people were allergic to peanuts, or about 1.5 percent of the population.

Interestingly, Romy Fischer, et al, in the American Journal of Pathology [2005; 167:1621-1630] say,

“We compared the oral and nasal routes of peanut sensitization for the development of a mouse model of allergy. Mice were sensitized by administration of peanut proteins in the presence of cholera toxin as adjuvant. Antibody and cytokine responses were characterized, as well as airway reactivity to nasal challenge with peanut or unrelated antigens. Oral sensitization promoted higher levels of IgE, but lower IgG responses, than nasal sensitization. Both orally and nasally sensitized mice experienced airway hyperreactivity on nasal peanut challenge.” http://ajp.amjpathol.org/cgi/content/full/167/6/1621

Their research basically demonstrates that inhalation of peanut protein/antigens is cause for concern.

Aside from the above information, aflatoxin, a toxic fungus produced by Aspergillus flavus, often is found on peanuts and causes anaphylaxis.

Surely one important aspect about allergic response that needs to be highlighted is this: According to the doctor who “found” alimentary anaphylaxis, Dr. Charles Richter (1913), food anaphylaxis resulted from proteins that had not been properly broken down or avoided modification by the digestive system. In today’s medical practice many physicians recognize what is termed “Leaky Gut Syndrome,” which acts similarly insofar as some undigested proteins cross the intestinal lumen and contribute to much health-related problems.

Perhaps now is an excellent opportunity to point out that many proteins used in the manufacture of vaccines—or that “result” from the manufacturing process, e.g., not filtered out completely—are injected directly into the blood stream and thereby avoid modification by the digestive system, another apparent factor in the etiology of vaccine adverse reactions in addition to the numerous toxic adjuvants included in each vaccine for boosted immune response, which most often are too strong for an infant’s immature immune system to cope with thereby precipitating “blown circuits” such as neurological damage.

Maybe because the U.S. Food and Drug Administration (FDA) considers refined peanut oil as GRAS (generally recognized as safe), vaccine manufacturers think it safe to use as a vaccine adjuvant while not recognizing the differences in physiology and function between food protein sources that are gut-digested from those syringed directly into the bloodstream. That issue could wind up becoming a critical learning for much of medicine, pharmaceutical and vaccine makers.

Further validation of peanut oil in a vaccine appeared in The New York Times, Business Financial Section page 31, September 19, 1964, under the headline:

“Peanut Oil Use In A New Vaccine.” It labeled peanut oil the key ingredient in Adjuvant 65 that was patented by Merck & Co., Inc. in September 1964. Ironically that article by Stacy V. Jones began with “A pharmaceutical manufacturer has developed a vaccine that it predicts will considerably lengthen immunity from influenza and other virus infections, thereby requiring fewer ‘shots’.” So much for their crystal ball gazing about fewer shots. If anything, they have manufactured and been influential in mandating more vaccinations than ever. Incidentally, Adjuvant 65, as a stand-alone product, supposedly is no longer used in the manufacture of vaccines in the United States.

Let’s review vaccinations that are mandated for infants and children:

Hepatitis B Vaccine: First dose at birth to 2 months; Second dose at 1 to 4 months; Third dose at 6 to 18 months

Hib vaccine: First dose at 2 months; Second dose at 4 months; Third dose at 6 months; Fourth dose at 12 to 15 months

Polio vaccine: First dose at 2 months; Second dose at 4 months; Third dose at 6 to 18 months; Fourth dose at 4 to 6 years

DTaP vaccine: First dose at 2 months; Second dose at 4 months; Third dose at 6 months; Fourth dose at 15 to 18 months; Fifth dose at 4 to 6 years; DTaP is recommended at 11 years

Pneumococcal vaccine: First dose at 2 months; Second dose at 4 months; Third dose at 6 months; Fourth dose at 12 to 18 months

Rotavirus vaccine: First dose at 2 months; Second dose at 4 months; Third dose at 6 months

Hepatitis A vaccine: First dose at 12 months; Second dose at 18 months

Influenza vaccine:First dose at 6 months (requires a booster one month after initial vaccine); Annually until 5 years (then yearly if indicated or desired, according to risks)

MMR vaccine: First dose at 12 to 15 months; Second dose at 4 to 6 years

Varicella vaccine: First dose at 12 to 15 months; Second dose at 4 to 6 years

Meningococcal vaccine: Single dose at 11 years

Human papillomavirus vaccine (adolescent girls only): First dose at 11 years; Second dose two months after first dose; Third dose six months after first dose

http://www.medicinenet.com/childhood_vaccination_schedule/article.htm

So, by the above schedule one easily can ascertain that infants, in particular, are being subjected to numerous adjuvants, the least of which is non-disclosed emulsified peanut oil. There are several articles about peanut use in vaccines in the literature. Furthermore, President George W. Bush’s government set in place in 1991 the goal of raising national vaccination levels among preschool children to 90 percent by the year 2000. [2]

Other oils used in the manufacture of vaccines can include mineral oil (paraffin), squalene (shark liver oil, which probably is the most dangerous of any oil), and at one time in the 1930s and 1940s, cottonseed oil. For more information on adverse effects of adjuvants in vaccines, visit this web site http://www.whale.to/vaccine/adjuvants.html#Oil_Emulsions_

Interestingly, Ms. Fraser points out in her book that Charles Janeway, a Howard Hughes Medical Institute investigator and Yale University School of Medicine professor in 1989, revealed that adjuvants were the “immunologists’ dirty little secret”. The secret was really a poorly understood puzzle regarding the body’s response to them. Janeway suggested that there are cross-reactive combinations of which researchers are unaware but which the body recognizes. [3]

Before I leave adjuvants, Doctor Buttram’s article mentioned Arlacel A, something I’d not heard of before. So I checked on it and found that it is a mono-oleate of manitol with the following information, which seems intriguing:

Dianhydro mannitol mono-oleate, a surfactant used in the preparation of water-in-oil injectable pharmaceutical preparations was found to autoxidize on storing, with the formation of free acidity and labile peroxides. The autoxidized substance was found to cause peritoneal adhesions when injected intraperitoneally in mice. The autoxidized material could be reclaimed by chromatography through alumina. The eluate was comparable to normal saline in toxicity and the adsorbate was found to be more toxic. http://www3.interscience.wiley.com/journal/113435337/abstract?CRETRY=1&SRETRY=0

An issue that, perhaps, has exacerbated infants’ adverse reactions to vaccines is the practice of their being injected with multiple immune-challenging vaccines at one time for convenience sake although no longitudinal studies have been undertaken for that type of protocol. Consider that, that is what happened to the six month old baby boy in this article.

As pointed out so succinctly in Fraser’s book, and with which I totally agree, “One of the side effects engendered by vaccine ingredients is the production of IgE antibodies.” [4] Doctor Buttram, who is a medical expert in environmental medicine, certainly is in his element when discussing such responses.

Fraser points out what Doctor Buttram has observed in his practice: “Doctors knew that as the number and potency of vaccines increased, so too would the risk of side effects that included soaring IgE and atopy [genetic tendency to develop classic allergy diseases, e.g., asthma, rhinitis, dermatitis, food sensitivities, especially in autistic children]. Anaphylaxis immediately following vaccination had finally become an ‘obstacle’ to the routine jab, doctors observed.” [5]

What all this seems to come down to is the fact that since the advent of the practice to administer numerous vaccines at one visit, there has been a rise in anaphylaxis—something not seen as dramatically or in such prolific numbers, as is attested to in the literature, plus the Autism Spectrum Disorder that effects male children predominately because of the supposed interaction with testosterone.

Shortly before Christmas 2009, Dr. Catherine Rice, PhD, of the Centers for Disease Control and Prevention (CDC) said that the rate of autism for U.S. children is one in every 110 children as of 2006! http://www.cnn.com/2009/HEALTH/12/17/autism.new.numbers/index.html

One glaring, if not gnawing, question all health consumers ought to be asking is: Why is the human infant brain affected by vaccines? According to Doctor Buttram’s paper, the brain has the highest fat content of any organ in the human body and, therefore, is susceptible to lipid peroxidation, The process whereby free radicals “steal” electrons from the lipids in our cell membranes, resulting in cell damage and increased production of free radicals. http://www.biochem.northwestern.edu/holmgren/Glossary/Definitions/Def-L/lipid_peroxidation.html

Furthermore, the Pourcyrous et al study out of the University of Tennessee with results published in the Journal Pediatrics, 2007; 151:167-172, indicates more answers to that question:

• Brain inflammation, as indicated by elevations of C-Reactive proteins.
• Brain edema, which can be assumed as one of the cardinal manifestations of inflammation.
• Potentially lethal cardiorespiratory events.
• Intraventricular brain hemorrhages—just what happened to the little fellow in this article.

Renowned brain surgeon Russell Blaylock’s research indicates over-stimulation for prolonged periods of time by vaccine adjuvants precipitates chronic inflammation, which, of course, is very destructive to the brain.

How convenient it would be to place the blame on Shaken Baby Syndrome and innocent parents whose lives are traumatized in numerous ways because of what their darling innocent infants and children are suffering through. Any parent knows the heartbreak and heartache of having a sick child. But when a child is permanently damaged because of medical procedures, as was indicated by the court in this case as probable vaccine damage and not Shaken Baby Syndrome, it’s time to demand answers from everyone: oversight health agencies at federal level, e.g., FDA, CDC, HHS; the medical profession, e.g., American Medical Association (AMA); pharmaceutical and vaccine makers both U.S. based and international; and from the U.S. Congress and its oversight powers.

Representative Carolyn B. Malloney (D-NY-14) introduced the Comparative Study of Vaccinated and Unvaccinated Populations Act of 2007 that went nowhere in 110^th Congress. Any bills that are not voted upon and passed as each two year congress ends, automatically become sine die or “dead.” They must be reintroduced into the next congress, as they don’t carry over. However, Congresswoman Malloney introduced a similar bill in the 109^th Congress and was supposed to do so in the 111^th, but apparently has not as of this late date in the waning half of the 111^th Congress.

As a consumer healthcare researcher, I cannot believe that members of the U.S. Congress would not want to investigate what’s going on with our children’s health and the relationship to vaccines. I can only conjecture that because of the heavy duty lobbying by vaccine makers with their deep pockets and gifting, that it is easier to believe in Shaken Baby Syndrome. Shame on anyone who believes vaccines cannot cause inflammation/swelling and damage the brain.

Note: The legal citation for the adjudication is Case No. JVJV002265 (Iowa Dist. Ct. June 1, 2010), for which I thank the defendants and their attorney.

References

1 Heather Fraser, The History of the Peanut Allergy Epidemic, (Hamilton, Canada: Expresso Book Machine, 2010) 141

2 Heather Fraser, The History of the Peanut Allergy Epidemic, (Hamilton, Canada: Expresso Book Machine, 2010) 131

3 Ibid, 127

4 Heather Fraser, The History of the Peanut Allergy Epidemic, (Hamilton, Canada: Expresso Book Machine, 2010) 142

5 Ibid, 156

*Correction – Dr. Harold Buttram’s paper presented for publication, “Subdural Hemorrhages Occurring in an Infant Immediately Following Vaccination,” methodically charted the infant’s anamnestic allergic response to vaccines at six months of age, not four as mentioned in the above article.

OneIndia.com
07/10/2010

Researchers are using computer programs to develop a fast and efficient method of generating vaccines for new strains of flu viruses.

Dimitris Papamichail, and a team of researchers from Stony Brook University have created algorithms that will design viruses that serve as live vaccines, which are then synthesized to specification.

The new method is called Synthetic Attenuated Virus Engineering (SAVE).

“Our approach is not only useful for influenza; it is also applicable to a wide range of viruses,” said Papamichail.

Read the rest of the article.

Mark Metherell
theage.com.au
July 3, 2010

AUSTRALIAN vaccine company CSL is again under scrutiny because of a failure to meet United States manufacturing standards.

However, the problems are not linked to the unexplained surge in convulsions among infants vaccinated with its product, regulators say.

The US Food and Drug Administration (FDA) has notified CSL of ”deviations” in good manufacturing practice in that CSL had failed to investigate thoroughly an ”unexplained discrepancy” in the formation of dark particles in its Alfuria flu vaccine, produced for the US market. The FDA report, based on a survey of the Melbourne plant undertaken in April, came just as the first of 100 cases of convulsions among infants vaccinated with CSL’s Fluvax flu product were occurring.

Read the rest of the article.

Shari Roan
LA Times
07/02/2010

Flu viruses mutate rapidly, meaning that vaccines against the flu have to be continually updated to target the latest strains. Moreover, antiviral medications to combat flu sometimes become ineffective because of viral mutations. Thus, finding a so-called universal flu vaccine that could be used against a wide range of viruses over a longer period of time has been a long-held dream of medical experts and the subject of a lot of research.

Scientists reported this week that they have taken another step toward a possible universal flu vaccine. They discovered a target on the influenza A virus that has not changed much — unlike other regions of the virus — called influenza matrix 2 protein (M2e). The researchers then found rare, naturally occurring antibodies in humans that target the protein. When these antibodies were given to mice infected with influenza, 60% to 80% recovered compared to a 10% survival rate in the untreated mice. The antibodies protected against two influenza strains: seasonal human H1N1 and an avian flu, H5N1.

Read the rest of the article here.